Shanxi Zhendong Pharmaceutical Co (SZSE:300158) Net Income From Continuing Operations : ¥-25 Mil (TTM As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Shanxi Zhendong Pharmaceutical Co Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Shanxi Zhendong Pharmaceutical Co's net income from continuing operations for the three months ended in Mar. 2024 was ¥22 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-25 Mil.

Shanxi Zhendong Pharmaceutical Co Net Income From Continuing Operations Historical Data

The historical data trend for Shanxi Zhendong Pharmaceutical Co's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanxi Zhendong Pharmaceutical Co Net Income From Continuing Operations Chart

Shanxi Zhendong Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Income From Continuing Operations

Get a 7-Day Free Trial

137.04

253.57

2,609.63

-57.00

-47.87

Shanxi Zhendong Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Income From Continuing Operations	Get a 7-Day Free Trial															-0.90	13.11	-16.34	-43.74	22.35

Shanxi Zhendong Pharmaceutical Co Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-25 Mil.

Shanxi Zhendong Pharmaceutical Co (SZSE:300158) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanxi Zhendong Pharmaceutical Co Ltd (SZSE:300158) » Definitions » Net Income From Continuing Operations

Traded in Other Exchanges

N/A

Address

Zhendong Technology Park, Guang Road, Changzhi County, Changzhi, CHN, SXI 047100

Website

http://en.zdjt.com

Shanxi Zhendong Pharmaceutical Co Ltd together with its subsidiaries, researches, develops, manufactures, and markets pharmaceutical products and Chinese medicines in China. It offers anticancer drugs, cardiovascular disease prevention and control drugs and anti-infection drugs among others. The company categorizes its product as Chinese & Western Medicine, Wuhe Food, Home Care Products and Traditional Chinese Medicine.

Executives

Miao Hui	Director
Ma Shi Feng	Executives
Li Zhi Xu	Executives
Li Xi Hai	Director
You Rong Li	Executives
Wang Xu Wen	Executives
Dong Mi Zhu	Directors, executives
Li Ren Hu	Supervisors
Ning Lu Hong	Directors, executives
Wang Li Qing	Supervisors
Jin Zhi Xiang	Supervisors

Shanxi Zhendong Pharmaceutical Co (SZSE:300158) Headlines

No Headlines